Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atypical presentation of chronic granulomatous disease with Burkholderia cepacia.

Literature DB >> 25103315

Atypical presentation of chronic granulomatous disease with Burkholderia cepacia.

Mac Vining¹, Nirupma Sharma², Margaret Guill³.

Abstract

Chronic granulomatous disease (CGD) is a rare inherited disorder of neutrophil oxidative burst. In patients with CGD, phagocyte destruction of catalase-producing organisms is impaired, resulting in recurrent and potentially fatal infections. Burkholderia cepacia, a catalase-producing organism, is known to infect patients with dysfunctional immune systems. We report a case of a 3-year-old boy with this rare infection that unravelled the diagnosis of CGD. 2014 BMJ Publishing Group Ltd.

Entities: Disease Gene Species

Mesh：

Substances：
Catalase

Year: 2014 PMID： 25103315 PMCID： PMC4127754 DOI： 10.1136/bcr-2013-201524

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

15 in total

1. Burkholderia cepacia infections in cystic fibrosis.

Authors: J L Burns; L Saiman
Journal: Pediatr Infect Dis J Date: 1999-02 Impact factor: 2.129

Review 2. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.

Authors: D Roos; M de Boer; F Kuribayashi; C Meischl; R S Weening; A W Segal; A Ahlin; K Nemet; J P Hossle; E Bernatowska-Matuszkiewicz; H Middleton-Price
Journal: Blood Date: 1996-03-01 Impact factor: 22.113

Review 3. Update on the Burkholderia cepacia complex.

Authors: John J Lipuma
Journal: Curr Opin Pulm Med Date: 2005-11 Impact factor: 3.155

4. Prognosis of chronic granulomatous disease.

Authors: A Finn; N Hadzić; G Morgan; S Strobel; R J Levinsky
Journal: Arch Dis Child Date: 1990-09 Impact factor: 3.791

5. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease.

Authors: S J Vowells; T A Fleisher; S Sekhsaria; D W Alling; T E Maguire; H L Malech
Journal: J Pediatr Date: 1996-01 Impact factor: 4.406

6. Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors: J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal: Medicine (Baltimore) Date: 2000-05 Impact factor: 1.889

7. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

Authors: J Liese; S Kloos; V Jendrossek; T Petropoulou; U Wintergerst; G Notheis; M Gahr; B H Belohradsky
Journal: J Pediatr Date: 2000-11 Impact factor: 4.406

8. An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips.

Authors: J E Repine; B Rasmussen; J G White
Journal: Am J Clin Pathol Date: 1979-05 Impact factor: 2.493

9. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center.

Authors: David E Greenberg; Joanna B Goldberg; Frida Stock; Patrick R Murray; Steven M Holland; John J Lipuma
Journal: Clin Infect Dis Date: 2009-06-01 Impact factor: 9.079